Increased CD8+ T-cell activation marked by heightened levels of Granzyme B secretion have been observed to have an antitumoral effect in vivo (45), and is associated with a positive prognosis in HNSCC (46). Here, CD8A is linked to head and neck squamous cell carcinoma.